|
Dec 22
|
cbdMD Reduces Year over Year Net Loss from Operations by $55.8 Million
|
|
Dec 20
|
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 Results
|
|
Aug 25
|
Paw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation Award
|
|
Aug 22
|
cbdMD, Inc. Suspends Monthly Dividend Payment on Its Series A Cumulative Convertible Preferred Stock
|